ArticleThe Journal of infection2021

Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: A meta-analysis.

Huan-Tee Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.